Skip to main content
. Author manuscript; available in PMC: 2017 May 12.
Published in final edited form as: Gene Ther. 2017 Feb 2;24(4):215–223. doi: 10.1038/gt.2017.4

Figure 1.

Figure 1

Change over time in serum cTn1 concentrations in TPP1−/− Dachshunds that received a TPP1 gene therapy vector via intracerebroventricular injection at 10 to11 weeks of age. In healthy normal dogs, including TPP1+/− Dachshunds from our colony, cTn1 levels are less than 0.1 ng/ml.